Interestingly, in our study, where the two targets with the highest correlation with miR-26a-5p, CDC6, and CCNE1 were also found to be proto-oncogenes [81–83], we confirmed via GEPIA (http://gepia.cancer-pku.cn/) that CDC6 and CCNE1 are highly expressed in most known tumors, which provides a breakthrough in our understanding of psoriasis treatment with anticancer drugs (Figure 6C). The gene discussed is CDC6; the disease is psoriasis.